Back to results
US 2003/0195189 A1Published application
Oxindole derivatives
AssigneeSmithKline Beecham Corporation
InventorsScott Howard Dickerson, David Harold Drewry, James A. Linn
Life of this patent
Estimating the term…
Abstract
Oxindole derivatives, specifically pyrrolo[3,2-f]quinoline-2-ones, which are useful as CDK4 inhibitors are described herein. The described invention also includes methods of making such oxindole derivatives as well as methods of using the same in the treatment of hyperproliferative diseases.
Claims45
A compound of Formula I
- 23
- or a salt, solvate, or a physiologically functional derivative thereof:
- wherein:
- R1 is (CR4R5)nNR2R3;
- n is 1 or 2;
- R2 and R3 are independently hydrogen, C1-6 alkyl, C1-6 alkenyl, C1-6 alkoxy-C1-6 alkyl, cycloalkyl, heterocyclyl, benzyl, phenyl, napthyl, heteroaryl, heteroaryl-C1-6 alkyl, or R2 and R3 together with the nitrogen to which they are bound form a 5 or 6 membered heterocyclic ring or a 5 to 7 membered heteroaryl ring, both rings optionally containing 1 or 2 additional oxygen, sulfur, S(O)m, or nitrogen atoms, said additional nitrogen atom being optionally substituted by a C1-6 alkyl or aryl group;
- m is 0, 1, or 2;
- R4 and R5 are independently hydrogen or C1-6 alkyl;
- and
- wherein any of said C1-6 alkyl, C1-6 alkenyl, C1-6 alkyl-C1-6 alkoxy, cycloalkyl, heterocyclyl, benzyl, phenyl, nalthyl, heteroaryl and heteroaryl-C1-6 alkyl groups can be optionally substituted with up to three members selected from a group consisting of halogen, hydroxyl, CF3 and N(CH3)2.
7 more elements
Dependencies are inferred from the claim text.